CYTEK BIOSCIENCES, INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $90.9M | $98.7M | $167.3M | $296.6M | $364.6M | $165.2M | $30.5M |
| Accounts Receivable | $62.5M | $60.6M | $55.9M | $48.9M | $29.8M | $17.0M | — |
| Inventory | $48.4M | $43.9M | $60.9M | $48.2M | $32.2M | $23.0M | — |
| Total Current Assets | $392.0M | $396.4M | $392.1M | $454.0M | $431.7M | $208.6M | — |
| Property, Plant & Equipment | $18.0M | $18.0M | $18.4M | $13.7M | $5.9M | $2.1M | — |
| Goodwill | $16.7M | $16.7M | $16.2M | $10.1M | $10.1M | $476.0K | — |
| Intangible Assets (Excl. Goodwill) | $16.8M | $20.1M | $23.1M | $4.3M | $4.7M | $274.0K | — |
| Total Assets | $461.5M | $499.5M | $494.5M | $519.5M | $463.3M | $220.0M | — |
| Liabilities | |||||||
| Accounts Payable | $6.4M | $5.5M | $3.0M | $4.8M | $3.0M | $2.9M | — |
| Total Current Liabilities | $77.8M | $67.7M | $56.2M | $49.0M | $33.2M | $26.5M | — |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $119.8M | $103.8M | $101.4M | $93.9M | $57.9M | $41.7M | — |
| Stockholders' Equity | |||||||
| Retained Earnings | $-101.7M | $-35.2M | $-29.2M | $-17.0M | $-19.6M | $-22.6M | — |
| Total Stockholders' Equity | $341.7M | $395.7M | $393.1M | $425.5M | $405.4M | $-16.0M | $41.7M |